Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 36 (2) , 339-344
- https://doi.org/10.1016/0091-3057(90)90414-d
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Exploration of mice in a black and white test box: Validation as a model of anxietyPublished by Elsevier ,2002
- The actions of nicotine and cocaine in a mouse model of anxietyPublished by Elsevier ,2002
- 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioningEuropean Journal of Pharmacology, 1988
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- The Anxiolytic and Anxiogenic Actions of Ethanol in a Mouse ModelJournal of Pharmacy and Pharmacology, 1988
- The benzodiazepine receptor inverse agonists β-CCM and RO 15–3505 both reverse the anxiolytic effects of ethanol in miceLife Sciences, 1988
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Withdrawal syndrome following subchronic treatment with anxiolytic agentsPharmacology Biochemistry and Behavior, 1987
- Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepinesPharmacology Biochemistry and Behavior, 1981